CSF1R inhibition by PLX3397 in patients with relapsed or refractory Hodgkin lymphoma: Results from a phase 2 single agent clinical trial Meeting Abstract
| Authors: | Moskowitz, C. H.; Younes, A.; de Vos, S.; Bociek, R. G.; Gordon, L. I.; Witzig, T. E.; Gascoyne, R. D.; West, B.; Nolop, K.; Steidl, C. |
| Abstract Title: | CSF1R inhibition by PLX3397 in patients with relapsed or refractory Hodgkin lymphoma: Results from a phase 2 single agent clinical trial |
| Meeting Title: | 54th Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 120 |
| Issue: | 21 |
| Meeting Dates: | 2012 Dec 8-11 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2012-11-01 |
| Language: | English |
| ACCESSION: | WOS:000314049601019 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V120.21.1638.1638 |
| Notes: | --- - Meeting Abstract: 1638 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos" |
